BSECompany Update5 Aug 2026 · 5 Aug 2026, 09:49 pm

Con Call audio link

Cohance Lifesciences Ltd · 543064

✦ AI SummaryResults

Cohance Lifesciences Ltd has uploaded the audio recording of its conference call for the quarter ended 30 June 2026 on its website.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Attachments (1)

📄

8a31e4d4-c7e6-4afe-b674-17d2bbea9442.pdf

pdf

Download →

View document text

5 August 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543064 Scrip Symbol: COHANCE Dear Sir/Madam, Sub: Audio recording of the conference call for the quarter ended 30 June 2026 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our results conference call intimation dated 23 July 2026, that audio recording of the conference call for the quarter ended 30 June 2026 held on Wednesday, 5 August 2026, has been uploaded on the Company's website and available at the link: https://www.cohance.com/wp-content/uploads/2026/08/Audio-5Aug26.mp3 This is for your information and record. Thanking you. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir k Mishra Company Secretary & Compliance Officer